Aspirin 81 mg
- Product NDC
- 63868-373
- 11-digit product format
- 638680373
- Labeler code
- 63868
- Product ID
- 63868-373_941f9db2-1b56-a2bc-e053-2995a90a18b0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ASPIRIN
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Chain Drug Marketing Association
- Application
- part343
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2014-06-13
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN
- Active strength
- 81 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63868-373-05 | Aspirin 81 mg | 500 in 1 BOTTLE, PLASTIC | TABLET, DELAYED RELEASE | 500 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| BROWN IRON OXIDE | INACTIVE INGREDIENT | 1N032N7MFO | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| DIACETYLATED MONOGLYCERIDES | INACTIVE INGREDIENT | 5Z17386USF | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | INACTIVE INGREDIENT | 74G4R6TH13 | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63868-373 | ASPIRIN 81 MG (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 3 | Legacy NDC, 1 package rows | 20241013_41a88e22-6272-4653-9df6-a71254caea0d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63868-373-05 | 63868037305 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (63868-373-05) | 2014-06-13 | 0000-00-00 | No | No | Current |